Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir plus ledipasvir for Chinese hepatitis C patients
ChiCTR-OPC-16008158Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ledipasvir in hepatitis C virus infection (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: HCV RNA. Started Mar 2016; status: recruiting.
02
Drugs
ledipasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ChiCTR-OPC-16008158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008158.